Literature DB >> 10593577

Tumor necrosis factor alpha and gamma interferon are required for the development of protective immunity to secondary Corynebacterium pseudotuberculosis infection in mice.

D T Lan1, S Makino, T Shirahata, M Yamada, A Nakane.   

Abstract

The production and role of endogenous cytokines during the course of secondary Corynebacterium (C.) pseudotuberculosis infection were investigated in mice. When immunized mice were challenged on day 28 after primary infection, tumor necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) were found to appear at 3 hr and to reach the maximum at 24 hr after challenge. Spleen cells of mice primarily infected from 2 to 8 weeks before produced a significant amount of TNF-alpha and IFN-gamma when stimulated with formalin-killed bacteria. However, they could not produce detectable amounts of IL-4. The administration of anti-TNF-alpha monoclonal antibody (MAb) and IFN-gamma MAb increased bacterial proliferation in the organs of immune mice and exacerbated the secondary infection. Injection of anti-CD4 MAb alone or anti-CD4 plus anti-CD8 MAbs resulted in significantly increased mortality and a marked suppression of bacterial elimination as well as cytokine production of secondarily infected mice, while the treatment with anti-CD8 MAb alone showed no effect on either the resistance or cytokine production of mice. These results suggest that CD4, probably Th1 T cells, play an important role for establishment of protective immunity against secondary C. pseudotuberculosis infection by secreting TNF-alpha and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593577     DOI: 10.1292/jvms.61.1203

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  6 in total

1.  Association between haptoglobin and IgM levels and the clinical progression of caseous lymphadenitis in sheep.

Authors:  Bruno L Bastos; Dan Loureiro; José T Raynal; Maria T Guedes; Vera Lúcia Costa Vale; Lilia F Moura-Costa; José E Guimarães; Vasco Azevedo; Ricardo W Portela; Roberto Meyer
Journal:  BMC Vet Res       Date:  2013-12-13       Impact factor: 2.741

2.  Quantitative Proteomic Analysis Reveals Changes in the Benchmark Corynebacterium pseudotuberculosis Biovar Equi Exoproteome after Passage in a Murine Host.

Authors:  Wanderson M Silva; Rodrigo D De Oliveira Carvalho; Fernanda A Dorella; Edson L Folador; Gustavo H M F Souza; Adriano M C Pimenta; Henrique C P Figueiredo; Yves Le Loir; Artur Silva; Vasco Azevedo
Journal:  Front Cell Infect Microbiol       Date:  2017-07-25       Impact factor: 5.293

3.  Sphingomyelinase D inhibits store-operated Ca2+ entry in T lymphocytes by suppressing ORAI current.

Authors:  David J Combs; Zhe Lu
Journal:  J Gen Physiol       Date:  2015-08       Impact factor: 4.086

4.  An iron-acquisition-deficient mutant of Corynebacterium pseudotuberculosis efficiently protects mice against challenge.

Authors:  Dayana Ribeiro; Flávia de Souza Rocha; Kátia Morais Costa Leite; Siomar de Castro Soares; Artur Silva; Ricardo Wagner Dias Portela; Roberto Meyer; Anderson Miyoshi; Sérgio Costa Oliveira; Vasco Azevedo; Fernanda Alves Dorella
Journal:  Vet Res       Date:  2014-03-06       Impact factor: 3.683

5.  Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression.

Authors:  Karina T O Santana-Jorge; Túlio M Santos; Natayme R Tartaglia; Edgar L Aguiar; Renata F S Souza; Ricardo B Mariutti; Raphael J Eberle; Raghuvir K Arni; Ricardo W Portela; Roberto Meyer; Vasco Azevedo
Journal:  Microb Cell Fact       Date:  2016-05-16       Impact factor: 5.328

6.  Humoral and cellular immune responses in mice against secreted and somatic antigens from a Corynebacterium pseudotuberculosis attenuated strain: Immune response against a C. pseudotuberculosis strain.

Authors:  Vera Lúcia Costa Vale; Marcos da Costa Silva; Andréia Pacheco de Souza; Soraya Castro Trindade; Lília Ferreira de Moura-Costa; Ellen Karla Nobre Dos Santos-Lima; Ivana Lucia de Oliveira Nascimento; Hugo Saba Pereira Cardoso; Edson de Jesus Marques; Bruno Jean Adrien Paule; Roberto José Meyer Nascimento
Journal:  BMC Vet Res       Date:  2016-09-08       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.